Becoming the Industry Leader
35 years of growth and innovation have made Amoena the industry leader.
Amoena was the first company to introduce revolutionary breast form innovations for breast cancer survivors. Unlike others in the industry, Cornelius was never satisfied with the status quo of breast forms. He continued to research ways to further innovate product design and comfort to create a form that felt more natural. In 1984, Amoena introduced a 2-layer breast form with a firm silicone ‘ring’ on the rear side to stabilise the form in the bra and a new shape that replicated the anatomy of a woman’s breast.
Technological advancement and diversification
Amoena has registered over 25 patent families and has a history rich in growth, technological advancements and diversification.
Here’s a glimpse at some of our proudest moments:
|Introduction of 2-layer breast forms
|Introduced patented Flowable Gel Back Layer breast forms
|Founded first Amoena subsidiaries in Europe
|First generation attachable breast forms after a patented manufacturing method
|Introduced a line of lingerie for breast cancer survivors post-surgery
|Launched pocketed swimwear
|Introduced lightweight silicone breast forms after a patented manufacturing method
|Introduced second generation attachable breast forms after a patented manufacturing method
|Introduced third generation attachable breast forms after a patented manufacturing method
|Patented Moldable Back Layer breast forms
|Introduced Tawny Lightweight breast forms
|Introduced patented Climate breast forms
|Patented Comfort+ Technology breast forms
|Introduced Amoena Energy breast forms with 3D pearl surface
|Launched Amoena's first bra product line designed for the general female consumer, Amoena Mia
Investment in growth
Whereas Cornelius initially had little or no interest from our industry, Amoena’s monumental growth and our position as industry leader eventually captured the attention of other companies. In 1994, Amoena Germany merged with the Breast Care Division of Coloplast A/S DK and eventually all Coloplast Breast Care subsidiaries became Amoena subsidiaries. Then, in 2007, Granville Baird Capital Partners invested in the Amoena Group because of our position as the global market leader.
Amoena serves worldwide post-mastectomy markets including North and Central America, Europe, the Far East, Africa and the Pacific Rim. We market products through hospitals and clinics, and through thousands of specialist boutiques and high-end retailers.
Cornelius's influence continues
Cornelius Rechenberg had a vision and a steadfast determination to revolutionize the manufacturing process of breast forms. Although he passed away in 2001, his influence continues to guide our company’s mission and values. We remain committed to Cornelius’s vision and the women we proudly serve.